Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 196

Sort by

Sort Order Select

Journal Articles

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Ani Gvajaia, MD, Amelia Langston, MD, Natia Esiashvil, MD, Michael Graiser, PhD, Kelly Valla, PharmD, Edmund K. Waller, PhDMD

Blood (2019) 134 (Supplement_1): 5657.

https://doi.org/10.1182/blood-2019-122467

Published: 2019

Journal Articles

Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia Patients at First Relapse: A Multi-Center Outcomes Analysis

Rachel Hu, MD, Wei Wei, MS, Kristen Gonter-Aubin, DO, Javier Pinilla Ibarz, MD PhD, Charlene C. Kabel, PharmD, Anthony R. Mato, MDMSCE, Yazan F. Madanat, MD, Sirin Khajavian, MD, Mazyar Shadman, MD, Ashley Hanlon, MD, Danielle M. Brander, MD, Jae H. Park, MD, Martin S. Tallman, MD, Brian T. Hill, MD

Blood (2019) 134 (Supplement_1): 4004.

https://doi.org/10.1182/blood-2019-126381

Published: 2019

Journal Articles

Total Skin Electron Beam Therapy in Patients with Advanced Cutaneous T Cell Lymphoma Undergoing Allogeneic Stem Cell Transplantation: A Single Centre Experience

Viviana Beatrice Valli, MD, Filippo Grillo Ruggieri, MD, Giorgia Saporiti, MD, Silvia Alberti Violetti, MD, Concetta Schiavone, MD, Federica Irene Grifoni, MD, Maria Cecilia Goldaniga, MD, Francesca Casarin, Valeria Ferla, MD, Luca Baldini, MD PhD, Emilio Berti, MD, Francesco Onida, MD

Blood (2019) 134 (Supplement_1): 2042.

https://doi.org/10.1182/blood-2019-131144

Published: 2019

Journal Articles

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment

Martin W. Schoen, MDMPH, Peter Georgantopoulos, MS, Nagasai S Yalavarthi, BS, Charles L. Bennett, MD PhD

Blood (2019) 134 (Supplement_1): 2135.

https://doi.org/10.1182/blood-2019-121770

Published: 2019

Journal Articles

No Improvement in Survival for T-PLL Patients over the Last Two Decades

Matthew J Cross, MBBS, BSc, Monica Else, Ricardo Morilla, Mark Edward Ethell, MD, Michael Potter, MD, Dima El-Sharkawi, Sunil Iyengar, MBBS, FRCPath, PhD, Claire E. Dearden, MD FRCP, FRCPath

Blood (2019) 134 (Supplement_1): 1552.

https://doi.org/10.1182/blood-2019-122094

Published: 2019

Journal Articles

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up

Blood (2019) 134 (Supplement_1): 1537.

https://doi.org/10.1182/blood-2019-127560

Published: 2019

Journal Articles

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis

Kristen Gonter-Aubin, DO, Daniel Alan Kerr, MD PhD, Ashley Rose, MD, Thanh Lana Nguyen, MDBS, Julio C. Chavez, MD, Javier Pinilla Ibarz, MD PhD

Blood (2019) 134 (Supplement_1): 1542.

https://doi.org/10.1182/blood-2019-129028

Published: 2019

Journal Articles

Down-Regulation of CD25 Antigen in Hairy Cell Leukemia Patients after Treatment

Mirela Anghelina, Narendranath Epperla, MD MS, Kerry A. Rogers, MD, Ling Guo, MD, Qiuhong Zhao, MS, James S. Blachly, MD, David M. Lucas, PhD, Christopher C. Oakes, Gerard Lozanski, MD, Michael R. Grever, MD, Leslie A. Andritsos, MD

Blood (2018) 132 (Supplement 1): 4143.

https://doi.org/10.1182/blood-2018-99-120043

Published: 2018

Journal Articles

Human Umbilical Cord Derived Mesenchymal Stromal Cells to Treat Steroid-Refractory Acute GvHD III/IV or Overlap Syndrome: Interim Analysis of a Multicenter Phase I/II Study

Maria Mico', Alessandra Algarotti, MD, Anna Grassi, MD, Chiara Pavoni, Statistician, Francesco Onida, MD, Nicola Mordini, Maria Luisa Ferrari, Federico Lussana, MD PhD, Maria Chiara Finazzi, MD, Daniela Taurino, MD, Chiara Capelli, Martino Introna, MD, Alessandro Rambaldi, MD PhD

Blood (2018) 132 (Supplement 1): 3404.

https://doi.org/10.1182/blood-2018-99-118444

Published: 2018

Journal Articles

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Muhammad Yasir, MD, Muhammad Junaid Tariq, MD, Arshia Akbar, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Muhammad Umair Jahngir, Ali Younas Khan, MD, Awais Ijaz, MD, Ceren Durer, MD, Seren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5559.

https://doi.org/10.1182/blood-2018-99-117084

Published: 2018

Journal Articles

Adverse Events Among Patients with Hairy Cell Leukemia Treated with Purine Nucleoside Analogs in the United States

Narendranath Epperla, MD, Melissa Pavilack, PharmD, Temitope O Olufade, PhD, Richa Bashyal, Jieni Li, Huseyin Yuce, Leslie Andritsos, MD

Blood (2018) 132 (Supplement 1): 4833.

https://doi.org/10.1182/blood-2018-99-115954

Published: 2018

Journal Articles

Infection at the Time of Initial Therapy for Hairy Cell Leukemia Is Associated with Inferior Time to Next Treatment

Narendranath Epperla, MDMS, Mirela Anghelina, Qiuhong Zhao, MS, Akwasi Agyeman, James S. Blachly, MD, Kerry A. Rogers, MD, Gerard Lozanski, MD, Christopher C. Oakes, Michael R. Grever, MD, Leslie Andritsos, MD

Blood (2018) 132 (Supplement 1): 2305.

https://doi.org/10.1182/blood-2018-99-119951

Published: 2018

Journal Articles

Second Line Systemic Treatments Including Extracorporeal Photopheresis Among Patients with Chronic Graft Versus Host Disease (cGVHD) in the United States, 2009-2016

Namita Joshi, PhD MS, BPharm, Linlin Luo, MSc, Xingyue Huang, PhD, Ghaith Mitri, MD, Belinda Lovelace, PharmD, An Pham, PharmD, MBA, FAHA, Xin Gao, PhD

Blood (2017) 130 (Supplement 1): 4490.

https://doi.org/10.1182/blood.V130.Suppl_1.4490.4490

Published: 2017

Journal Articles

Results from the Phase 3 DUO TM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Blood (2017) 130 (Supplement 1): 493.

https://doi.org/10.1182/blood.V130.Suppl_1.493.493

Published: 2017

Journal Articles

Haploidentical Natural Killer Cell Infusion Induces Remission in Non-Hodgkin Lymphoma and Overcomes Resistance to Rituximab

Veronika Bachanova, MD, Dhifaf Sarhan, PhD, Todd E. DeFor, MS, Sarah Cooley, MD, Angela Panoskaltsis-Mortari, PhD, Michael R. Verneris, MD, Bruce R. Blazar, MD, Julie Curtsinger, PhD, Linda J. Burns, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD

Blood (2016) 128 (22): 3030.

https://doi.org/10.1182/blood.V128.22.3030.3030

Published: 2016

Journal Articles

Characteristics, Outcomes and Treatment of Patients with T-Cell Prolymphocytic Leukemia (T-PLL) - Single-Center Experience

Etsuko Aoki, MDPhD, Preetesh Jain, MBBS, MDDM, PhD, Alessandra Ferrajoli, MD, Zeev Estrov, MD, Michael Keating, MBBS, Susan M. O'Brien, MD, William G. Wierda, MD PhD, Nitin Jain, MD, Philip A Thompson, MBBS, Elias Jabbour, MD, Sherry Pierce, BSN, BA, Chitra Hosing, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Tapan M. Kadia, MD

Blood (2016) 128 (22): 2997.

https://doi.org/10.1182/blood.V128.22.2997.2997

Published: 2016

Journal Articles

Trametinib for the Treatment of IGHV4-34, MAP2K1 Mutant Variant Hairy Cell Leukemia

Leslie A. Andritsos, MD, Mirela Anghelina, MD, Nicole R. Grieselhuber, MD PhD, Sameek Roychowdhury, MD PhD, Julie Reeser, PhD, Cynthia Timmers, PhD, Aharon G. Freud, MD PhD, James S. Blachly, MD, David M. Lucas, PhD, Gerard Lozanski, MD, Jeffrey Jones, MD MPH, Kerry A. Rogers, MD, Weiqiang Zhao, MD PhD, Michael R. Grever, MD

Blood (2016) 128 (22): 5598.

https://doi.org/10.1182/blood.V128.22.5598.5598

Published: 2016

Journal Articles

Reversal of Low Donor Chimerism Following Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion

Merav Bar, MD, Mary Flowers, MD, Barry E. Storer, PhD, Thomas R. Chauncey, MD PhD, Michael A Pulsipher, MD, Monica S Thakar, MD, Wolfgang Bethge, MD, Rainer F. Storb, MD, David G Maloney, Brenda M. Sandmaier, MD

Blood (2016) 128 (22): 2215.

https://doi.org/10.1182/blood.V128.22.2215.2215

Published: 2016

Journal Articles

Cytogenetics in Hairy Cell Leukemia at Diagnosis and Relapse: The Rate of Therapy-Related Myeloid Malignancies Is Low

Bartlomiej Getta, MBBS,, Omar Abdel-Wahab, Jae H. Park, MD, Martin S Tallman, MD

Blood (2015) 126 (23): 2644.

https://doi.org/10.1182/blood.V126.23.2644.2644

Published: 2015

Journal Articles

Successful Salvage Therapy By Idelalisib Followed By Haploidentical Allogenic Transplantation of an Alemtuzumab-Refractory T-Cell Prolymphocytic Leukemia

Julien Lenglet, MD, Amélie Trinquand, MD, Ludovic Lhermitte, MD PhD, Ali Bazarbachi, MD PhD, Laurent Frenzel, MD PhD, Olivier Tournilhac, MD PhD, Olivier Hermine

Blood (2015)

https://doi.org/10.1182/blood.V126.23.5071.5071

Published: 2015

NARROW

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia Patients at First Relapse: A Multi-Center Outcomes Analysis

Total Skin Electron Beam Therapy in Patients with Advanced Cutaneous T Cell Lymphoma Undergoing Allogeneic Stem Cell Transplantation: A Single Centre Experience

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment

No Improvement in Survival for T-PLL Patients over the Last Two Decades

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis

Down-Regulation of CD25 Antigen in Hairy Cell Leukemia Patients after Treatment

Human Umbilical Cord Derived Mesenchymal Stromal Cells to Treat Steroid-Refractory Acute GvHD III/IV or Overlap Syndrome: Interim Analysis of a Multicenter Phase I/II Study

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Adverse Events Among Patients with Hairy Cell Leukemia Treated with Purine Nucleoside Analogs in the United States

Infection at the Time of Initial Therapy for Hairy Cell Leukemia Is Associated with Inferior Time to Next Treatment

Second Line Systemic Treatments Including Extracorporeal Photopheresis Among Patients with Chronic Graft Versus Host Disease (cGVHD) in the United States, 2009-2016

Results from the Phase 3 DUO TM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Haploidentical Natural Killer Cell Infusion Induces Remission in Non-Hodgkin Lymphoma and Overcomes Resistance to Rituximab

Characteristics, Outcomes and Treatment of Patients with T-Cell Prolymphocytic Leukemia (T-PLL) - Single-Center Experience

Trametinib for the Treatment of IGHV4-34, MAP2K1 Mutant Variant Hairy Cell Leukemia

Reversal of Low Donor Chimerism Following Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion

Cytogenetics in Hairy Cell Leukemia at Diagnosis and Relapse: The Rate of Therapy-Related Myeloid Malignancies Is Low

Successful Salvage Therapy By Idelalisib Followed By Haploidentical Allogenic Transplantation of an Alemtuzumab-Refractory T-Cell Prolymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only